Abbott Laboratories
BMV:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
|
General Dynamics Corp
NYSE:GD
|
US |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
H
|
Hexindo Adiperkasa Tbk PT
IDX:HEXA
|
ID |
|
Japan Post Bank Co Ltd
OTC:JPSTF
|
JP |
|
Airbus SE
OTC:EADSF
|
NL |
|
TC Energy Corp
TSX:TRP
|
CA |
|
N
|
Novo Nordisk A/S
XBER:NOV
|
DK |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 2 100.95 MXN with a low forecast of 1 599.52 MXN and a high forecast of 2 584.68 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
2 100.95
MXN
According to Wall Street analysts, the average 1-year price target for ABT is 2 100.95 MXN with a low forecast of 1 599.52 MXN and a high forecast of 2 584.68 MXN.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
